Melatonin is a pleotropic molecule with numerous biological activities. Epidemiological and
experimental studies have documented that melatonin could inhibit different types of cancer …

The epidemiological studies have indicated a possible oncostatic property of melatonin on
different types of tumors. Besides, experimental studies have documented that melatonin …

Fatigue is the most common symptom experienced by patients during the cancer trajectory
from diagnosis to the end of life and is defined as a distressing, persistent, subjective sense …

Nutrients | Free Full-Text | Is Melatonin the “Next Vitamin D”?: A Review of
Emerging Science, Clinical Uses, Safety, and Dietary Supplements Next Article in Journal …

Introduction Neo/adjuvant therapy for early-stage breast cancer has become increasingly
common in the last few decades; as a consequence, the number of breast cancer survivors …

Melatonin is a fascinating molecule that has captured the imagination of many scientists
since its discovery in 1958. In recent times, the focus has changed from investigating its …

This randomized, double-blinded, placebo-controlled trial tested the hypothesis that 20mg of
melatonin before and during the first cycle of adjuvant chemotherapy for breast cancer …

There is considerable evidence that melatonin may be of use in the prevention and
treatment of cancer. This manuscript will review some of the human, animal and cellular …

Melatonin is an endogenous indoleamine with an incredible variety of properties and
activities. In recent years, an increasing number of studies have investigated this …

Objective: Fatigue associated with malignant conditions and their treatments is a disabling
condition. This trial assessed the anti-fatigue effects of melatonin coadministration during …